Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,946
Closed -$8.8K 5786
2025
Q4
$8.8K Buy
1,946
+1,827
+1,535% +$9.36K ﹤0.01% 4000
2025
Q3
$641 Buy
+119
New +$644 ﹤0.01% 4480

Farther Finance Advisors's CVAC Position: Q1 2026 in Review

Farther Finance Advisors sold out of CureVac (CVAC) in Q1 2026, closing a stake of 1,946 shares — an estimated $8.8K sold.

Farther Finance Advisors first reported a position in CVAC in Q3 2025 and held it in 2 quarters. The position peaked at $8.8K in Q4 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

  • Farther Finance Advisors reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
  • Farther Finance Advisors sold 1,946 CureVac shares in Q1 2026, an estimated $8.8K.
  • Farther Finance Advisors first reported a position in CureVac in Q3 2025 and held it in 2 quarters.
  • Farther Finance Advisors's CureVac position peaked at $8.8K in Q4 2025.
  • 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Farther Finance Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.